New Assurance Rich Clonality Based Workflows for Commercial Cell and Gene Therapy Laboratories

Watch Advanced Instrument’s presentation at 5th Bioprocessing of Biotherapeutics and explore four Solentim technologies, that are designed for single cell cloning and assurance of monoclonality. Dr. Duncan Borthwick describes advances in clonally based workflows including cell line development, gene therapy and cell therapy.

This presentation includes:

• Understanding the Regulatory and practical benefits of clonally-derived workflows
• Latest approaches for antibody, iPSC derived cell therapy and viral vector approaches
• Data management and quality considerations.